- Investing Ideas
- /
- German Pharmaceuticals & Biotech High Growth Potential Companies
German Pharmaceuticals & Biotech High Growth Potential Companies
Results
7
Companies with a Future performance score of at least 3, ordered by Future performance score.
7 companies
Cantourage Group
Market Cap: €42.4m
Operates as a medical cannabis company in Europe.
HIGH
€3.40
7D
-7.4%
1Y
-32.7%
SynBiotic
Market Cap: €19.9m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€2.93
7D
0%
1Y
-50.8%
Formycon
Market Cap: €398.3m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.55
7D
-1.7%
1Y
-57.2%
Gerresheimer
Market Cap: €1.2b
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€35.00
7D
-20.3%
1Y
-63.9%
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€6.04
7D
-4.0%
1Y
-1.0%
Apontis Pharma
Market Cap: €91.2m
Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APPH
€10.95
7D
0.5%
1Y
65.4%
Bayer
Market Cap: €26.8b
Operates as a life science company worldwide.
BAYN
€27.25
7D
-1.1%
1Y
-6.4%